Characteristics of Atopic Dermatitis Patients Treated with Crisaborole: Real-World Data from a Large Healthcare Provider Database in Israel
Clara Weil,1,* Roni Adiri,2,* Gabriel Chodick,1,3 Merril Gersten,2 Eran Cohen Barak4,5 1Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel; 2Pfizer Israel, Herzliya Pituah, Israel; 3Faculty of Medicine, Tel Aviv University, Tel Aviv, Isra...
Saved in:
Main Authors: | Weil C (Author), Adiri R (Author), Chodick G (Author), Gersten M (Author), Cohen Barak E (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis
by: Joseph Fowler, et al.
Published: (2023) -
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
by: Eric L. Simpson, et al.
Published: (2018) -
Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
by: Clara Weil, et al.
Published: (2023) -
Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis
by: Darya Pavlenko, et al.
Published: (2023) -
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis
by: Eric L. Simpson, et al.
Published: (2019)